Urgent

Palliative care in the last days of life — anticipatory prescribing & syringe driver (CSCI; care of the dying adult)

Palliative / end-of-life · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recognising dying and providing proactive symptom control in the last days of life. Core elements: recognise irreversible dying and agree goals with patient/family; stop non-essential interventions and medicines; prescribe individualised anticipatory ('just in case') subcutaneous medicines for the 5 common terminal symptoms (pain, breathlessness, nausea/vomiting, respiratory secretions, agitation/restlessness); and start a continuous subcutaneous infusion (syringe driver / CSCI) when more than 2-3 as-required doses are needed in 24 hours. Doses below are starting-dose guides for an opioid-naive adult with normal renal function — verify against local formulary and reduce in frailty/renal impairment.

Red flags

  • A potentially reversible cause of deterioration that the patient would want treated (sepsis, hypercalcaemia, opioid toxicity, obstruction) — do not mislabel as dying
  • Opioid toxicity mistaken for terminal agitation (myoclonus, pinpoint pupils) — reduce/rotate opioid, consider renal impairment
  • Terminal agitation due to urinary retention or faecal impaction — relieve mechanically before sedating
  • Family/carer distress or disagreement about recognising dying — needs clear communication, not just prescribing
  • Haemorrhage, major seizure or acute severe breathlessness — crisis anticipatory plan (midazolam, opioid) should be in place

Assessment

Differential diagnosis

  • Confirm dying is irreversible vs a reversible deterioration (infection, hypercalcaemia, AKI, opioid toxicity, delirium cause, obstruction) that the patient would want treated
  • Distinguish terminal agitation from reversible causes: urinary retention, constipation/impaction, pain, hypoxia, drug toxicity, nicotine/alcohol/benzodiazepine withdrawal
  • Distinguish respiratory secretions (death rattle) from pulmonary oedema/infection

Investigations

  • Clinical recognition of dying (multidisciplinary) — generally no new investigations in the actively dying
  • Review and rationalise medicines; convert essential oral drugs to SC route
  • Check for and treat reversible contributors ONLY if consistent with goals (e.g. catheterise for retention, treat hypercalcaemia if appropriate)
  • Document ReSPECT/DNACPR, preferred place of care/death, and communicate plan with family

Management

  • Recognise and sensitively communicate that the person is dying; agree an individualised care plan with patient (if able) and those important to them
  • Review all medications: stop non-essential drugs (statins, antihypertensives, oral hypoglycaemics, bisphosphonates); continue/convert essential symptom-control drugs to subcutaneous route
  • Prescribe anticipatory SC medicines PRN for all 5 symptoms so there is no delay: analgesic (opioid), antiemetic, sedative/anxiolytic (midazolam), antisecretory, and ensure water for injection
  • Ensure attention to mouth care, pressure-area care, continence, positioning, and psychological/spiritual/family support
  • If >2-3 PRN doses needed in 24 h, or oral route lost, start a continuous subcutaneous infusion (CSCI/syringe driver) over 24 h; add the total PRN used to the background
  • For pain in an opioid-naive patient: use PRN morphine; if already on oral opioid, convert to SC equivalent (oral morphine to SC morphine divide by 2) for the driver, with breakthrough = 1/6 of 24-h SC dose
  • For secretions: reposition; start an antimuscarinic early (effect is on NEW secretions); reassure family it is usually not distressing to the patient
  • For terminal agitation/restlessness: exclude reversible causes (retention, pain, impaction), then midazolam PRN/CSCI; add levomepromazine or haloperidol if delirium/agitation persists
  • Review at least daily (or more often); titrate; check syringe-driver site and drug compatibility

Drugs & doses

Morphine sulfate 2.5-5 mg SC PRN hourly for pain/breathlessness (opioid-naive); CSCI start 10 mg/24 h, titrate (reduce dose & frequency in renal impairment/frailty) [verify local dose]
If already on opioid: convert oral morphine to SC by dividing by 2 for the CSCI; breakthrough = 1/6 of the 24-h SC dose [verify local dose]
Oxycodone SC as morphine alternative (esp. renal impairment): oxycodone 1-2.5 mg SC PRN / CSCI start ~5 mg/24 h [verify local dose]
Midazolam 2.5-5 mg SC PRN hourly for agitation/breathlessness/seizures; CSCI start 10 mg/24 h (range to 30-60 mg) [verify local dose]
Levomepromazine 12.5-25 mg SC PRN / 25-50 mg/24 h CSCI for terminal agitation/delirium or nausea (broad-spectrum; sedating) [verify local dose]
Haloperidol 0.5-1.5 mg SC PRN (nausea) or 2.5-5 mg for agitation/delirium; CSCI 1.5-5 mg/24 h (nausea) or up to 10 mg/24 h (agitation) [verify local dose]
Hyoscine butylbromide (Buscopan) 20 mg SC PRN / 60-120 mg/24 h CSCI for respiratory secretions (does not cross BBB; preferred) [verify local dose]
Glycopyrronium 200 micrograms SC PRN / 600-1200 micrograms/24 h CSCI as antisecretory alternative [verify local dose]
Hyoscine hydrobromide 400 micrograms SC PRN / 1.2-2.4 mg/24 h CSCI (antisecretory but sedating/can cause paradoxical agitation) [verify local dose]
Cyclizine 50 mg SC PRN / 100-150 mg/24 h CSCI for nausea (NOTE: incompatible with hyoscine butylbromide and precipitates at higher concentrations in a driver) [verify local dose]
Water for injection as CSCI diluent; check drug compatibility before combining in one syringe

Disposition

Supportive care in preferred place (home with community team, hospice, or ward). Ensure anticipatory meds, syringe driver, out-of-hours plan and family support in place; specialist palliative care for complex/refractory symptoms.

Complications & pitfalls

  • Uncontrolled symptoms from under-prescribing or delayed syringe driver
  • Over-sedation / opioid toxicity from conversion error or renal impairment
  • Syringe-driver drug incompatibility/precipitation, site reactions
  • Family distress, complicated grief if communication poor; moral/legal concern if dying mislabelled (Gosport learning)

Exam pearls

  • Guidance: NICE NG31 (care of dying adults in the last days of life); Palliative Care Formulary; Scottish Palliative Care Guidelines.
  • Anticipatory prescribing = prescribe all 5 symptom drugs 'just in case' so there is never a delay reaching medication at home or on the ward.
  • Start a syringe driver if more than 2-3 PRN doses are needed in 24 h, or the oral route is lost.
  • Antisecretory drugs only prevent NEW secretions — start early and manage family expectations; death rattle rarely distresses the patient.
  • Always exclude retention, impaction, pain and opioid toxicity before attributing agitation to 'terminal restlessness'.
  • Hyoscine butylbromide and glycopyrronium do not cross the blood-brain barrier (less sedation) and are preferred over hyoscine hydrobromide; cyclizine is incompatible with hyoscine butylbromide in a driver.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.